Ampullary Cancer
Uludag University, Faculty of Medicine describes research in ampullary cancer
Published in Clinical Oncology Week, July 30th, 2007
Researchers detail in "Periampullary carcinomas," new data in ampullary cancer. According to recent research from Bursa, Turkey, "The purpose of this study was to determine predictors of survival after resection for periampullary neoplasms. In this study, we reevaluated our 17 cases of this type tumor which we had reported as periampullar site tumors, in advanced stages with undetermined localization, in our pathology department of the Uludag University faculty of medicine. Six of our cases were female, and 11 were male with a mean age of 60.6 years (range 31-77)."
"Their main complaints were loss of weight, anorexia, jaundice and fatigue. Physical and endoscopic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Breast Cancer
High Fiber/Low Fat Diet Does Not Appear to Reduce Risk of Breast Cancer Recurrence More Than ‘5-A-Day’ Diet - Breast Cancer
Src inhibitors may prove beneficial in breast cancer therapy - Breast Cancer
The '2-week wait rule' is failing breast cancer patients - Cancer
Could a Suntan be Protective? - Cancer
Study Estimates Cancer Risk From Radiation Exposure During Cardiac CT Scans - Cancer Vaccines
Immune system 'escape hatch' gives cancer cells traction - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
